Nasal therapy-The missing link in optimising strategies to improve prevention and treatment of COVID-19

PLoS Pathog. 2021 Nov 24;17(11):e1010079. doi: 10.1371/journal.ppat.1010079. eCollection 2021 Nov.

Authors

Norman A Ratcliffe^{1

2}, Helena C Castro¹, Izabel C Paixão^{1

3}, Victor G O Evangelho¹, Patricia Azambuja^{1

4}, Cicero B Mello^{1

4}

Affiliations

¹ Programa de Pós-Graduação em Ciências e Biotecnologia, IB, Universidade Federal Fluminense, Niterói, Brazil.
² Department of Biosciences, Swansea University, Swansea, United Kingdom.
³ Laboratório de Virologia Molecular e Biotecnologia Marinha, IB, Universidade Federal Fluminense, Niterói, Brazil.
⁴ Laboratório de Bioquimica e Biotecnologia, IB, Universidade Federal Fluminense, Niterói, Brazil.

No abstract available

MeSH terms

Administration, Intranasal / methods*
Administration, Intranasal / trends
Antiviral Agents / administration & dosage
COVID-19 / prevention & control*
COVID-19 / therapy
COVID-19 / transmission*
Humans
Receptors, Virus / drug effects
Receptors, Virus / metabolism
SARS-CoV-2 / pathogenicity

Substances

Antiviral Agents
Receptors, Virus

Grants and funding

The authors received no specific funding for this work.